Qiagen N.V. (QGEN) Recent Earnings

Qiagen N.V. (QGEN) reported 4th Quarter December 2017 earnings of $0.43 per share on revenue of $396.9 million. The consensus earnings estimate was $0.42 per share on revenue of $393.0 million. Revenue grew 8.3% on a year-over-year basis.

Qiagen NV provides sample and assay technologies. It also offers kits, assays, related automated systems and bioinformatics solutions, that cover the entire continuum from basic life sciences research to clinical diagnostics.